Dyslipidemia and lower extremity arterial disease

被引：0

作者：

Paraskevas, Kosmas I. ^{[1
]}

Poredos, Pavel ^{[2
]}

Stanek, Agata ^{[3
,4
]}

Blinc, Ales ^{[2
,5
]}

Jawien, Arkadiusz ^{[6
]}

Antignani, Pier Luigi ^{[7
]}

Mansilha, Armando ^{[8
]}

Mikhailidis, Dimitri P. ^{[9
,10
]}

机构：

[1] Red Cross Hosp, Dept Vasc Surg, 24 Alex Papagou St, Athens 14122, Greece

[2] Univ Med Ctr Ljubljana, Dept Vasc Dis, Ljubljana, Slovenia

[3] Med Univ Silesia, Fac Med Sci Zabrze, Dept Internal Med Angiol & Phys Med, Bytom, Poland

[4] Med Univ Silesia, Clin Internal Med Angiol & Phys Med, Fac Med Sci Zabrze, Bytom, Poland

[5] Univ Ljubljana, Fac Med, Dept Internal Med, Ljubljana, Slovenia

[6] Nicolaus Copernicus Univ Torun, Dept Vasc Surg & Angiol, L Rydygier Coll Med Bydgoszcz, Torun, Poland

[7] Nuova Villa Claudia, Vasc Ctr, Rome, Italy

[8] Univ Porto, Hosp S Joao, Dept Angiol & Vasc Surg, Porto, Portugal

[9] Univ Coll London UCL, Univ Coll London Med Sch, Dept Surg Biotechnol, Div Surg & Intervent Sci, London, England

[10] Univ Coll London UCL, Royal Free Hosp Campus, Dept Clin Biochem, London, England

来源：

INTERNATIONAL ANGIOLOGY | 2024年

关键词：

Dyslipidemia; Peripheral arterial disease; Lower extremity arterial disease; Statins; Surgical amputation; AMPUTATION-FREE SURVIVAL; CRITICAL LIMB ISCHEMIA; STATIN THERAPY; LIPID MANAGEMENT; RISK-FACTORS; MORTALITY; CHOLESTEROL; OUTCOMES; ASSOCIATION; LIPOPROTEIN;

D O I：

10.23736/S0392-9590.24.05266-0

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Introduction: Dyslipidemia is an established risk factor for cardiovascular diseases. We aimed to review its role in the pathogenesis of lower extremity arterial disease (LEAD), as well as the effect of lipid-lowering treatment on the progression of LEAD. Evidence acquisition: PubMed/MedLine, EMBASE and Scopus were searched between January 1990 and January 2024 for articles investigating the role of dyslipidemias and hyperlipidemias in the pathogenesis of LEAD. A separate search focused on the effects of lipid-lowering therapy on patients with LEAD. Evidence synthesis: There is evidence that dyslipidemias play a major role in the development of LEAD. All patients with LEAD should receive intensive lipid-lowering therapy for the reduction not only of claudication symptoms and amputation rates, but also of myocardial infarction and cardiovascular event rates. Conclusions: Vascular specialists should keep in mind the pivotal role of dyslipidemia in the pathogenesis and progression of LEAD.

引用

页数：8

共 50 条

[31] Reproductive factors and lower extremity arterial occlusive disease in women
Holzer, Gerold
Koschat, Martin A.
Kickinger, Wolfgang
Clementi, Wolfgang
Holzer, Lukas A.
Metka, Markus M.
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (08) : 505 - 511
[32] Implications of the timely diagnosis of lower extremity peripheral arterial disease
Paraskevas, Kosmas I.
Mikhailidis, Dimitri P.
Giannoukas, Athanasios D.
Veith, Frank J.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (03) : 551 - 551
[33] Antithrombotic Therapy in Lower Extremity Arterial Disease and Aortic Diseases
Espinola-Klein, Christine
AKTUELLE KARDIOLOGIE, 2022, 11 (06) : 560 - 564
[34] Patients with upper extremity arterial disease have similar major adverse clinical events as those with lower extremity arterial disease
Chi, Yung-Wei
Woods, T. Cooper
CIRCULATION, 2007, 116 (16) : 775 - 776
[35] ARTERIAL RECONSTRUCTION OF THE LOWER-EXTREMITY FOR CHRONIC OBLITERATING DISEASE
DEWEESE, JA
HELVETICA CHIRURGICA ACTA, 1985, 52 (02) : 345 - 345
[36] Perfusion imaging techniques in lower extremity peripheral arterial disease
Galanakis, Nikolaos
Maris, Thomas G.
Kontopodis, Nikolaos
Tsetis, Konstantinos
Kehagias, Elias
Tsetis, Dimitrios
BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1135):
[37] Intravascular Lithotripsy in the Treatment of Lower Extremity Peripheral Arterial Disease
Hatzis, Christopher M.
George, Justin M.
Ilonzo, Nicole
Price, Lucyna
Tadros, Rami O.
SURGICAL TECHNOLOGY INTERNATIONAL-INTERNATIONAL DEVELOPMENTS IN SURGERY AND SURGICAL RESEARCH, 2021, 39
[38] Hormone replacement therapy and the risk of lower extremity arterial disease
Westendorp, ICD
Bots, ML
Grobbee, DE
Pols, HAP
Hofman, A
Witteman, CM
CIRCULATION, 1999, 100 (18) : 871 - 871
[39] Underutilisation of duplex scanning for the assessment of lower extremity arterial disease
Legemate, DA
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1997, 13 (02) : 96 - 97
[40] Impact of metabolic syndrome in patients with lower extremity arterial disease
Aursulesei, V.
Cozma, A.
Popa, R.
Datcu, M. D.
EUROPEAN HEART JOURNAL, 2009, 30 : 652 - 653

← 1 2 3 4 5 →